Heron Therapeutics: 3Q Earnings Snapshot

November 7, 2018

SAN DIEGO (AP) _ Heron Therapeutics Inc. (HRTX) on Wednesday reported a loss of $38.3 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 49 cents.

The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.

The pharmaceutical company posted revenue of $19.8 million in the period, topping Street forecasts. Four analysts surveyed by Zacks expected $18.6 million.

Heron Therapeutics shares have risen 72 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $31.11, a climb of 94 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HRTX at https://www.zacks.com/ap/HRTX

Update hourly